The best inhalers for the prevention of asthma
and the treatment of acute asthmatic episodes.

Chronic obstructive pulmonary disease (COPD) is a pathologic disorder of the lung works during which it is difficult to breathe. This process develops within a long time and may be caused by chronic bronchitis, pulmonary emphysema, smoking, and others.

COPD often appears because of the prolonged inflammatory processes in the respiratory tracts. A lot of mucus is discharged during the inflammation, the walls of bronchi are thickened and lumen of the respiratory tracts becomes lower. Due to this, a human experiences shortness of breath, and cough, labored breathing (increasing during the physical activity) appears; an intense discharge of sputum is noticed during coughing.

COPD constantly progresses. As a result of the prolonged obstruction of the airway tracts, a vital capacity of the lungs is reduced, shortness of breath appears seldom during insignificant physical loads (stair climbing, eating, slow walking). The symptoms of this disease may be stronger at some point, and a human will need urgent medical aid to breathe.

Early diagnostics and COPD treatment will save your life. If you experience unnatural shortness of breath, severe prolonged cough, whistling in the chest or other signs of the inflammation of the respiratory tracts bother you, visit a doctor.

If you go to a doctor in time, it is possible to prevent the development of COPD and stop the inflammatory processes in the respiratory tracts. But if you were diagnosed COPD, it is necessary to begin a maintaining medical therapy. To maintain a respiratory function, patients are offered several ways of the treatment depending on the cause of the pathology and its severity.

It is medically proved that an administration of Spiriva or other bronchodilating drugs is an effective and safe method of the COPD treatment. Why is Spiriva one of the best drugs for the treatment of COPD?

Spiriva contains tiotropium bromide which is not a hormonal drug and has a good tolerance. Many bronchodilating products have a short period of the action, and therefore they should be often used, and this is not convenient.

Spiriva should be used once per day. Unlike glucocorticosteroid drugs, Spiriva does not cause severe side effects and has a moderate action to the body. Of course, glucocorticoids will be needed on the final stage of COPD because the treatment will be unsuccessful. But Spiriva works better as a prolonged maintaining therapy.

The use of Spiriva dilates the respiratory tracts, improves a ventilation of the lungs, enhances a vital capacity of the lungs. The frequency and intensity of the attacks of the shortness of breath are reduced during the use of the drug, and COPD stops progressing.

Anti-inflammatory products and antibiotics which will help to reduce inflammatory processes in the respiratory tracts, stop a development of infection (if it is observed) and increase the efficiency of Spiriva may be used.

Spiriva is not a panacea for chronic obstructive pulmonary disease, and many patients are recommended to have rehabilitation during the diseases of lungs and to learn to control the attacks.